Mingzhi Zhang

Chinese Academy of Sciences — China

Medicine · Health Sciences

38h-index5.4kcitations355works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(151), Viral-associated cancers and disorders(49), CAR-T cell therapy research(48), Chronic Lymphocytic Leukemia Research(45), Immune Cell Function and Interaction(31)

Publications355 total

Spatial Mapping of Membrane Protein Interactions Using a DNA Origami Rubbing
Angewandte Chemie·2026
Spatial Mapping of Membrane Protein Interactions Using a DNA Origami Rubbing
Angewandte Chemie International Edition·2026Open Access
From Tea to Topical Agent: Machine Learning and Bioinformatics Reveal KU DING Tea’s Anti-UV Ingredients and Mechanisms
Pharmaceuticals·2025Open Access
GNAQ inhibits tumorigenesis via the ARHGEF25-mediated RHOA pathway in NK/T-cell lymphoma
Cancer Biology & Therapy·2025Open Access
Phase 1 study of MK-1045, a novel CD19xCD3 T-cell engager, in participants with relapsed or refractory follicular lymphoma
Blood·2025Open Access
Longitudinal ctdna tracking by low-pass whole-genome sequencing during CD19 CAR-T cell therapy for B-cell lymphomas
Blood·2025
Phase 1 study of MK-1045, a novel CD19xCD3 T-cell engager, in participants with relapsed or refractory diffuse large B-cell lymphoma
Blood·2025Open Access
Updated real-world outcomes with brentuximab vedotin in lymphoma patients: A multicenter, retrospective study from China
Blood·2025Open Access
Testicular lymphoma of 63 patients: a Chinese retrospective, real-world study
Frontiers in Oncology·2025Open Access
Improving diagnosis and management of pediatric ovarian masses: development of a risk stratification model incorporating sonographic and clinical features
2025Open Access
Predicting viscosity of multiple slag system using BO-CatBoost and SHapley Additive exPlanations analysis
Journal of Iron and Steel Research International·2025
ABO Blood Group and the Risk and Prognosis of Diffuse Large B-Cell Lymphoma
Cancer Management and Research·2025Open Access
[Clinical Features, Prognostic Analysis and Predictive Model Construction of Central Nervous System Invasion in Peripheral T-Cell Lymphoma].
PubMed·2025
The small molecule drug CBL0137 interferes with DNA damage repair and enhances the sensitivity of NK/T-Cell lymphoma to cisplatin
Cancer Biology & Therapy·2025Open Access
MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B‐Cell Lymphoma
Hematological Oncology·2025Open Access
Spatial transcriptomics study of Castleman disease
Journal of Translational Medicine·2025· 2 citedOpen Access
Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicenter analysis in China
Cancer Letters·2025· 8 cited
Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma
Annals of Hematology·2025· 3 citedOpen Access
PD-L1 knockout or ZG16 overexpression inhibits PDAC progression and modulates TAM polarization
Frontiers in Immunology·2025· 1 citedOpen Access
Economic burden and health-related quality of life in Chinese patients with mycosis fungoides and Sézary syndrome
Cancer Pathogenesis and Therapy·2025· 1 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Ken H. Young(16), Ling Li(14), Zhaoming Li(11), Zijun Y. Xu‐Monette(9), Yong Li(9), Yu Chang(9), Zhi‐Yuan Zhou(8), Xiaorui Fu(8), Jianguo Wen(7), Zhenchang Sun(7), Jiaqin Yan(7), Xinhua Wang(6), Xiaoran Li(6), Yaqing Li(6), Zhenhe Suo(6), Jingjing Wu(6), Feifei Nan(6), Qipan Deng(5), Eric D. Hsi(5), Lei Zhang(5)